Cargando…
Liver Metastatic Breast Cancer: Epidemiology, Dietary Interventions, and Related Metabolism
The median overall survival of patients with metastatic breast cancer is only 2–3 years, and for patients with untreated liver metastasis, it is as short as 4–8 months. Improving the survival of women with breast cancer requires more effective anti-cancer strategies, especially for metastatic diseas...
Autores principales: | Zuo, Qianying, Park, Nicole Hwajin, Lee, Jenna Kathryn, Madak Erdogan, Zeynep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228756/ https://www.ncbi.nlm.nih.gov/pubmed/35745105 http://dx.doi.org/10.3390/nu14122376 |
Ejemplares similares
-
ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors
por: Mogol, Ayca, et al.
Publicado: (2022) -
THU558 Combination Therapy Of Acetyl-CoA Synthetase Inhibitor And Fulvestrant Reverse Epigenetic Alterations Of Metastatic Breast Cancer Cells And Reduce Cancer Cell Proliferation
por: Mogol, Ayca N, et al.
Publicado: (2023) -
ODP563 Breast Cancer With Liver Metastasis Responds Poorly to Fulvestrant-Based Combination Therapy and Chemotherapy
por: Chien, Christine, et al.
Publicado: (2022) -
Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers
por: Cotul, Eylem Kulkoyluoglu, et al.
Publicado: (2020) -
Biomarkers of Broccoli Consumption: Implications for Glutathione Metabolism and Liver Health
por: Eve, Alicia Arredondo, et al.
Publicado: (2020)